Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Retinitis Pigmentosa Global Market Report 2025
Request Sample Buy Now
Global Retinitis Pigmentosa Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Retinitis Pigmentosa Global Market Report 2025

By Type (Autosomal Recessive, Autosomal Dominant, X-Linked), By Treatment (Vitamin A, Docosahexaenoic Acid (DHA), Calcium Channel Blockers, Gene Therapy, Retinal Eye Prosthetics, Other Treatments), By Diagnosis (Electroretinogram, Visual Field Testing, Genetic Testing, Other Diagnosis), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels), By End-users (Hospitals, Specialty Clinics, Homecare, Other End-users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Retinitis Pigmentosa Market Overview

• Retinitis Pigmentosa market size has reached to $11.32 billion in 2024

• Expected to grow to $16.81 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%

• Growth Driver: Rising Healthcare Expenditure Drives Growth In The Retinitis Pigmentosa Market

• Market Trend: Innovative Gene Therapy Developments In Retinitis Pigmentosa

• North America was the largest region in 2024.

What Is Covered Under Retinitis Pigmentosa Market?

Retinitis pigmentosa (RP) is a group of inherited disorders causing progressive degeneration of the retina, leading to vision loss. It primarily affects photoreceptor cells (rods and cones), resulting in symptoms such as night blindness and tunnel vision. Over time, RP can lead to significant visual impairment and blindness.

The main types of retinitis pigmentosa are autosomal recessive, autosomal dominant, and x-linked. Autosomal recessive retinitis pigmentosa (AR-RP) is a form of disease where a person must inherit two copies of the mutated gene, one from each parent, to be affected. The treatment of retinitis pigmentosa includes vitamin A, docosahexaenoic acid (DHA), calcium channel blockers, Gene Therapy, retinal eye prosthetics, and others, and is diagnosed by electroretinogram, visual field testing, genetic testing, and others. The distribution channels include hospital pharmacies, retail pharmacies, online pharmacies, and others, and they are used by various end-users such as hospitals, specialty clinics, home care, and others.

Retinitis Pigmentosa Market Size and growth rate 2025 to 2029: Graph

What Is The Retinitis Pigmentosa Market Size 2025 And Growth Rate?

The retinitis pigmentosa market size has grown strongly in recent years. It will grow from $11.32 billion in 2024 to $12.15 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to genetic research advancements, the development of retinal imaging technologies, increased awareness campaigns, growing patient advocacy groups, and the expansion of clinical trial networks.

What Is The Retinitis Pigmentosa Market Growth Forecast?

The retinitis pigmentosa market size is expected to see strong growth in the next few years. It will grow to $16.81 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to advancements in stem cell research for retinal regeneration, personalized medicine approaches, increased investment in orphan drug development, and expansion of telemedicine services. Major trends in the forecast period include a shift towards combination therapies, a rise in patient-centric clinical trial designs, the adoption of value-based pricing models, and the integration of digital therapeutics.

The forecast of 8.5% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of gene therapy vectors and retinal prosthetics sourced from the UK and Canada, thereby slowing innovative treatment access and elevating genetic disorder management expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Retinitis Pigmentosa Market Segmented?

1) By Type: Autosomal Recessive, Autosomal Dominant, X-Linked

2) By Treatment: Vitamin A, Docosahexaenoic Acid (DHA), Calcium Channel Blockers, Gene Therapy, Retinal Eye Prosthetics, Other Treatments

3) By Diagnosis: Electroretinogram, Visual Field Testing, Genetic Testing, Other Diagnosis

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-users: Hospitals, Specialty Clinics, Homecare, Other End-users

Subsegments:

1) By Autosomal Recessive: Early-Onset Autosomal Recessive Retinitis Pigmentosa, Late-Onset Autosomal Recessive Retinitis Pigmentosa

2) By Autosomal Dominant: Early-Onset Autosomal Dominant Retinitis Pigmentosa, Late-Onset Autosomal Dominant Retinitis Pigmentosa

3) By X-Linked: X-Linked Recessive Retinitis Pigmentosa, X-Linked Dominant Retinitis Pigmentosa

What Is Driving The Retinitis Pigmentosa Market? Rising Healthcare Expenditure Drives Growth In The Retinitis Pigmentosa Market

The increase in healthcare expenditure is expected to propel the growth of the retinitis pigmentosa market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare goods and services, including medical treatments, medications, hospitalizations, and preventive care, within a specified period, reflecting the overall cost of healthcare provision within a population. Healthcare expenditure is rising due to the increasing cost of advanced medical technologies, aging populations, and the prevalence of chronic diseases. Healthcare expenditure for retinitis pigmentosa is focused on advancing diagnostic methods, developing effective treatments, and providing supportive care to manage vision loss. For instance, in January 2024, according to the National Institutes of Health, a US-based government agency, healthcare expenditure in the US rose by 4.1% in 2022 to reach $4.5 trillion, representing a faster growth rate compared to the 3.2% increase observed in 2021. Therefore, the increase in healthcare expenditure is driving the growth of the retinitis pigmentosa industry.

Who Are The Major Players In The Global Retinitis Pigmentosa Market?

Major companies operating in the retinitis pigmentosa market are Johnson & Johnson, Novartis AG, AbbVie Inc., Astellas Pharma Inc., Biogen Inc., Sun Pharmaceutical Industries Ltd, Spark Therapeutics, REGENXBIO Inc., Editas Medicine, IVERIC bio, MeiraGTx Holdings, Gensight Biologics, Second Sight Medical Products, Copernicus Therapeutics Inc., Kiora Pharmaceuticals, 4D Molecular Therapeutics, ReNeuron Group, Acucela Inc., AGTC (Applied Genetic Technologies Corporation), Editgene

What Are The Key Trends Of The Global Retinitis Pigmentosa Market? Innovative Gene Therapy Developments In Retinitis Pigmentosa

Major companies operating in the retinitis pigmentosa market are increasingly focusing on developing innovative treatment options, such as gene therapy, to provide more effective and targeted solutions for managing and potentially curing this debilitating condition. Gene therapy for retinitis pigmentosa (RP) involves the delivery of functional genes to replace or repair the defective ones causing the disease. This innovative treatment aims to restore normal function to the affected photoreceptor cells in the retina, thereby slowing or potentially halting the progression of vision loss. For instance, in April 2024, ViGeneron GmbH, a Germany-based biotechnology company, launched a Phase Ib clinical trial to evaluate the safety, tolerability, and efficacy of VG901, a gene therapy designed to treat retinitis pigmentosa (RP) caused by mutations in the CNGA1 gene. The trial is an open-label, single-arm, dose-escalation study that will investigate the intravitreal injection of VG901 in patients with autosomal recessive RP due to biallelic CNGA1 mutations.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Retinitis Pigmentosa Market? Thea Pharma Acquires Antisense Oligonucleotide Treatments From ProQR Therapeutics To Strengthen Focus On Genetic Eye Diseases

In December 2023, Thea Pharma Inc., a France-based pharmaceutical company, acquired two antisense oligonucleotide (AON) treatments, Sepofarsen (LCA10) and Ultevursen (USH2A), from ProQR Therapeutics NV for an undisclosed amount. This acquisition supports Thea's focus on rare genetic eye diseases and ophthalmology. ProQR Therapeutics NV is a Netherlands-based biotechnology company that focuses on developing treatments for retinitis pigmentosa.

What Is The Regional Outlook For The Global Retinitis Pigmentosa Market?

North America was the largest region in the retinitis pigmentosa market in 20244 The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Retinitis Pigmentosa Market?

The retinitis pigmentosa market consists of revenues earned by entities by providing services such as genetic counseling, low vision therapy, psychological support, and educational support. The market value includes the value of related goods sold by the service provider or included within the service offering. The retinitis pigmentosa market also includes sales of retinal implants, screen readers, telescopic glasses, and adaptive lighting. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Retinitis Pigmentosa Industry?

The retinitis pigmentosa market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the retinitis pigmentosa industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Retinitis Pigmentosa Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $12.15 billion
Revenue Forecast In 2034 $16.81 billion
Growth Rate CAGR of 8.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Autosomal Recessive, Autosomal Dominant, X-Linked
2) By Treatment: Vitamin A, Docosahexaenoic Acid (DHA), Calcium Channel Blockers, Gene Therapy, Retinal Eye Prosthetics, Other Treatments
3) By Diagnosis: Electroretinogram, Visual Field Testing, Genetic Testing, Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-users: Hospitals, Specialty Clinics, Homecare, Other End-users Subsegments: 1) By Autosomal Recessive: Early-Onset Autosomal Recessive Retinitis Pigmentosa, Late-Onset Autosomal Recessive Retinitis Pigmentosa
2) By Autosomal Dominant: Early-Onset Autosomal Dominant Retinitis Pigmentosa, Late-Onset Autosomal Dominant Retinitis Pigmentosa
3) By X-Linked: X-Linked Recessive Retinitis Pigmentosa, X-Linked Dominant Retinitis Pigmentosa
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Johnson & Johnson, Novartis AG, AbbVie Inc., Astellas Pharma Inc., Biogen Inc., Sun Pharmaceutical Industries Ltd, Spark Therapeutics, REGENXBIO Inc., Editas Medicine, IVERIC bio, MeiraGTx Holdings, Gensight Biologics, Second Sight Medical Products, Copernicus Therapeutics Inc., Kiora Pharmaceuticals, 4D Molecular Therapeutics, ReNeuron Group, Acucela Inc., AGTC (Applied Genetic Technologies Corporation), Editgene
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Retinitis Pigmentosa Market Characteristics

3. Retinitis Pigmentosa Market Trends And Strategies

4. Retinitis Pigmentosa Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Retinitis Pigmentosa Growth Analysis And Strategic Analysis Framework

5.1. Global Retinitis Pigmentosa PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Retinitis Pigmentosa Market Growth Rate Analysis

5.4. Global Retinitis Pigmentosa Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Retinitis Pigmentosa Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Retinitis Pigmentosa Total Addressable Market (TAM)

6. Retinitis Pigmentosa Market Segmentation

6.1. Global Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Autosomal Recessive

Autosomal Dominant

X-Linked

6.2. Global Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vitamin A

Docosahexaenoic Acid (DHA)

Calcium Channel Blockers

Gene Therapy

Retinal Eye Prosthetics

Other Treatments

6.3. Global Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Electroretinogram

Visual Field Testing

Genetic Testing

Other Diagnosis

6.4. Global Retinitis Pigmentosa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Other Distribution Channels

6.5. Global Retinitis Pigmentosa Market, Segmentation By End-users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Homecare

Other End-users

6.6. Global Retinitis Pigmentosa Market, Sub-Segmentation Of Autosomal Recessive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Early-Onset Autosomal Recessive Retinitis Pigmentosa

Late-Onset Autosomal Recessive Retinitis Pigmentosa

6.7. Global Retinitis Pigmentosa Market, Sub-Segmentation Of Autosomal Dominant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Early-Onset Autosomal Dominant Retinitis Pigmentosa

Late-Onset Autosomal Dominant Retinitis Pigmentosa

6.8. Global Retinitis Pigmentosa Market, Sub-Segmentation Of X-Linked, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

X-Linked Recessive Retinitis Pigmentosa

X-Linked Dominant Retinitis Pigmentosa

7. Retinitis Pigmentosa Market Regional And Country Analysis

7.1. Global Retinitis Pigmentosa Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Retinitis Pigmentosa Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Retinitis Pigmentosa Market

8.1. Asia-Pacific Retinitis Pigmentosa Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Retinitis Pigmentosa Market

9.1. China Retinitis Pigmentosa Market Overview

9.2. China Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Retinitis Pigmentosa Market

10.1. India Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Retinitis Pigmentosa Market

11.1. Japan Retinitis Pigmentosa Market Overview

11.2. Japan Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Retinitis Pigmentosa Market

12.1. Australia Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Retinitis Pigmentosa Market

13.1. Indonesia Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Retinitis Pigmentosa Market

14.1. South Korea Retinitis Pigmentosa Market Overview

14.2. South Korea Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Retinitis Pigmentosa Market

15.1. Western Europe Retinitis Pigmentosa Market Overview

15.2. Western Europe Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Retinitis Pigmentosa Market

16.1. UK Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Retinitis Pigmentosa Market

17.1. Germany Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Retinitis Pigmentosa Market

18.1. France Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Retinitis Pigmentosa Market

19.1. Italy Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Retinitis Pigmentosa Market

20.1. Spain Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Retinitis Pigmentosa Market

21.1. Eastern Europe Retinitis Pigmentosa Market Overview

21.2. Eastern Europe Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Retinitis Pigmentosa Market

22.1. Russia Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Retinitis Pigmentosa Market

23.1. North America Retinitis Pigmentosa Market Overview

23.2. North America Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Retinitis Pigmentosa Market

24.1. USA Retinitis Pigmentosa Market Overview

24.2. USA Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Retinitis Pigmentosa Market

25.1. Canada Retinitis Pigmentosa Market Overview

25.2. Canada Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Retinitis Pigmentosa Market

26.1. South America Retinitis Pigmentosa Market Overview

26.2. South America Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Retinitis Pigmentosa Market

27.1. Brazil Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Retinitis Pigmentosa Market

28.1. Middle East Retinitis Pigmentosa Market Overview

28.2. Middle East Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Retinitis Pigmentosa Market

29.1. Africa Retinitis Pigmentosa Market Overview

29.2. Africa Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Retinitis Pigmentosa Market Competitive Landscape And Company Profiles

30.1. Retinitis Pigmentosa Market Competitive Landscape

30.2. Retinitis Pigmentosa Market Company Profiles

30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Retinitis Pigmentosa Market Other Major And Innovative Companies

31.1. Sun Pharmaceutical Industries Ltd

31.2. Spark Therapeutics

31.3. REGENXBIO Inc.

31.4. Editas Medicine

31.5. IVERIC bio

31.6. MeiraGTx Holdings

31.7. Gensight Biologics

31.8. Second Sight Medical Products

31.9. Copernicus Therapeutics Inc.

31.10. Kiora Pharmaceuticals

31.11. 4D Molecular Therapeutics

31.12. ReNeuron Group

31.13. Acucela Inc.

31.14. AGTC (Applied Genetic Technologies Corporation)

31.15. Editgene

32. Global Retinitis Pigmentosa Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Retinitis Pigmentosa Market

34. Recent Developments In The Retinitis Pigmentosa Market

35. Retinitis Pigmentosa Market High Potential Countries, Segments and Strategies

35.1 Retinitis Pigmentosa Market In 2029 - Countries Offering Most New Opportunities

35.2 Retinitis Pigmentosa Market In 2029 - Segments Offering Most New Opportunities

35.3 Retinitis Pigmentosa Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Retinitis Pigmentosa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Retinitis Pigmentosa Market, Segmentation By End-users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Retinitis Pigmentosa Market, Sub-Segmentation Of Autosomal Recessive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Retinitis Pigmentosa Market, Sub-Segmentation Of Autosomal Dominant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Retinitis Pigmentosa Market, Sub-Segmentation Of X-Linked, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Retinitis Pigmentosa Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Retinitis Pigmentosa Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Johnson & Johnson Financial Performance
  • Table 80: Novartis AG Financial Performance
  • Table 81: AbbVie Inc. Financial Performance
  • Table 82: Astellas Pharma Inc. Financial Performance
  • Table 83: Biogen Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Retinitis Pigmentosa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Retinitis Pigmentosa Market, Segmentation By End-users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Retinitis Pigmentosa Market, Sub-Segmentation Of Autosomal Recessive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Retinitis Pigmentosa Market, Sub-Segmentation Of Autosomal Dominant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Retinitis Pigmentosa Market, Sub-Segmentation Of X-Linked, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Retinitis Pigmentosa Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Retinitis Pigmentosa Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Retinitis Pigmentosa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Retinitis Pigmentosa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Retinitis Pigmentosa Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Johnson & Johnson Financial Performance
  • Figure 80: Novartis AG Financial Performance
  • Figure 81: AbbVie Inc. Financial Performance
  • Figure 82: Astellas Pharma Inc. Financial Performance
  • Figure 83: Biogen Inc. Financial Performance

Next-Gen Healthcare Services : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Healthcare Services : Market Forecast, Transformation, and Long-Term Trajectories

Hospitals And Outpatient Care Centers Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Hospitals And Outpatient Care Centers Growth Trajectory: Key Forecasts and Strategic Insights

ICU Beds Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About ICU Beds Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the ICU Beds Market Landscape: Innovative Products In Influenza Diagnostic Market Development

Read More About Emerging Trends Redefining the ICU Beds Market Landscape: Innovative Products In Influenza Diagnostic Market Development

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Hydrotherapy Equipment Market 2024 – By Type (Chambers, Tanks, Hydrotherapy Pools, Hydrotherapy Tub, Bath, Underwater Treadmill, Other Types), By Application (Pain Management, Dermatology, Cardiology, Other Applications)...

View Report

RNA Targeting Small Molecules Therapeutics Global Market Report 2025 – By Offering (mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Ta...

View Report

External Pacemakers Global Market Report 2025 – By Product (Single Chamber, Dual Chamber), By Application (Bradycardia, Acute Myocardial Infarction), By End-user (Hospitals, Ambulatory Surgical Centers, Other End-Users) ...

View Report

Automotive Cup Holder Global Market Report 2025 – By Type (Fixed Cup Holders, Folding Cup Holders, Removable Cup Holders, Built-In Cup Holders), By Material (Plastic Cup Holders, Metal Cup Holders, Synthetic Fiber Cup Ho...

View Report

Ketolides Global Market Report 2025 – By Drug Type (Telithromycin, Cethromycin, Solithromycin), By Indication (Bronchitis, Pneumonia, Sinusitis, Tonsillitis Or Pharyngitis), By Microorganism (Streptococcus Pneumoniae, Ha...

View Report

Pharmacy Automation Solution Global Market Report 2025 – By Type (Automated Medication Dispensing, Automated Packaging And Labeling, Automated Storage And Retrieval, Automated Medication Compounding, Other Types), By Aut...

View Report

Unit Dose Manufacturing Global Market Report 2025 – By Product (Liquid Unit Dose, Solid Unit Dose, Other Products), By Sourcing (In-House, Outsourcing), By End-User (Independent Pharmacies, Long Term Care Facility, Hospi...

View Report

Artificial Saliva Global Market Report 2025 – By Product (Oral Spray, Oral Solution, Oral Liquid, Dissolving Tablets, Gel, Powder), By Distributional Channel (Supermarkets, Hypermarkets, Other Distribution Channels), By ...

View Report

Frequently Asked Questions

Retinitis pigmentosa (RP) is a group of inherited disorders causing progressive degeneration of the retina, leading to vision loss. It primarily affects photoreceptor cells (rods and cones), resulting in symptoms such as night blindness and tunnel vision. Over time, RP can lead to significant visual impairment and blindness. For further insights on this market, request a sample here

The market major growth driver - Rising Healthcare Expenditure Drives Growth In The Retinitis Pigmentosa Market. For further insights on this market, request a sample here

The retinitis pigmentosa market size has grown strongly in recent years. It will grow from $11.32 billion in 2024 to $12.15 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to genetic research advancements, the development of retinal imaging technologies, increased awareness campaigns, growing patient advocacy groups, and the expansion of clinical trial networks. The retinitis pigmentosa market size is expected to see strong growth in the next few years. It will grow to " $16.81 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to advancements in stem cell research for retinal regeneration, personalized medicine approaches, increased investment in orphan drug development, and expansion of telemedicine services. Major trends in the forecast period include a shift towards combination therapies, a rise in patient-centric clinical trial designs, the adoption of value-based pricing models, and the integration of digital therapeutics. For further insights on this market, request a sample here

The retinitis pigmentosamarket covered in this report is segmented –
1) By Type: Autosomal Recessive; Autosomal Dominant; X-Linked
2) By Treatment: Vitamin A; Docosahexaenoic Acid (DHA); Calcium Channel Blockers; Gene Therapy; Retinal Eye Prosthetics; Other Treatments
3) By Diagnosis: Electroretinogram; Visual Field Testing; Genetic Testing; Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
5) By End-users: Hospitals; Specialty Clinics; Homecare; Other End-users Subsegments:
1) By Autosomal Recessive: Early-Onset Autosomal Recessive Retinitis Pigmentosa; Late-Onset Autosomal Recessive Retinitis Pigmentosa
2) By Autosomal Dominant: Early-Onset Autosomal Dominant Retinitis Pigmentosa; Late-Onset Autosomal Dominant Retinitis Pigmentosa
3) By X-Linked: X-Linked Recessive Retinitis Pigmentosa; X-Linked Dominant Retinitis Pigmentosa For further insights on this market, request a sample here

North America was the largest region in the retinitis pigmentosa market in 20244 The regions covered in the retinitis pigmentosa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the retinitis pigmentosa market are Johnson & Johnson, Novartis AG, AbbVie Inc., Astellas Pharma Inc., Biogen Inc., Sun Pharmaceutical Industries Ltd, Spark Therapeutics, REGENXBIO Inc., Editas Medicine, IVERIC bio, MeiraGTx Holdings, Gensight Biologics, Second Sight Medical Products, Copernicus Therapeutics Inc., Kiora Pharmaceuticals, 4D Molecular Therapeutics, ReNeuron Group, Acucela Inc., AGTC (Applied Genetic Technologies Corporation), Editgene. For further insights on this market, request a sample here.

Major trends in this market include Innovative Gene Therapy Developments In Retinitis Pigmentosa. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Retinitis Pigmentosa Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon